- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Catalyst Pharmaceuticals Inc (CPRX)
19.970
-0.110(-0.55%)
Closed
After Hours
19.600-0.370(-1.853%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.820
20.102
52 wk Range
11.890
21.665
CPRX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Assess today's live Catalyst Pharmaceuticals Inc (CPRX) share price, performance and insights using our live NASDAQ: CPRX stock exchange data.
Analyse the historical data and Catalyst Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Catalyst Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Catalyst Pharmaceuticals (CPRX) stock price today with other investors in the Catalyst Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CPRX share price (ISIN: US14888U1016) to enhance your trading decisions with our free investment tools and resources.
What Is the Catalyst Pharmaceuticals Inc Share Price Today?
The Catalyst Pharmaceuticals share price today is 19.970.
What Is the Stock Symbol for Catalyst Pharmaceuticals Inc
The stock symbol (or 'ticker') for Catalyst Pharmaceuticals Inc is "CPRX."
What Stock Exchange Does Catalyst Pharmaceuticals Inc Trade On?
Catalyst Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Catalyst Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Catalyst Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Catalyst Pharmaceuticals Inc share price performance charts on this page. Our technical summary section provides analysis on Catalyst Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Catalyst Pharmaceuticals (CPRX) stock price today with other investors in the Catalyst Pharmaceuticals NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CPRX share price (ISIN: US14888U1016) to enhance your trading decisions with our free investment tools and resources.
What Is the Catalyst Pharmaceuticals Inc Share Price Today?
The Catalyst Pharmaceuticals share price today is 19.970.
What Is the Stock Symbol for Catalyst Pharmaceuticals Inc
The stock symbol (or 'ticker') for Catalyst Pharmaceuticals Inc is "CPRX."
What Stock Exchange Does Catalyst Pharmaceuticals Inc Trade On?
Catalyst Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Catalyst Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Catalyst Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
19.82020.102
52 wk Range
11.89021.665
UnlockCPRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
30.143
Upside
+50.941%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- FIRDAPSE gains approval for LEMS treatment in Japan
- Investing.com
- FIRDAPSE gains approval for LEMS treatment in Japan
- Investing.com
Catalyst Pharmaceuticals Company Profile
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was founded in 2002 and is based in Coral Gables, Florida.
Compare CPRX to Peers and Sector
Metrics to compare | CPRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCPRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 34.8x | −0.6x | −0.6x | |
PEG Ratio | −0.81 | 0.03 | 0.00 | |
Price/Book | 3.9x | 1.6x | 2.6x | |
Price / LTM Sales | 5.5x | 8.3x | 3.3x | |
Upside (Analyst Target) | 50.2% | 305.5% | 49.0% | |
Fair Value Upside | Unlock | 25.9% | 7.7% | Unlock |
People Also Watch
FAQ
What Is the Catalyst Pharmaceuticals (CPRX) Stock Price Today?
The Catalyst Pharmaceuticals stock price today is 19.97
What Stock Exchange Does Catalyst Pharmaceuticals Trade On?
Catalyst Pharmaceuticals is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Catalyst Pharmaceuticals?
The stock symbol for Catalyst Pharmaceuticals is "CPRX."
What Is the Catalyst Pharmaceuticals Market Cap?
As of today, Catalyst Pharmaceuticals market cap is 2.37B.
What is Catalyst Pharmaceuticals Earnings Per Share?
The Catalyst Pharmaceuticals EPS is 0.608.
What Is the Next Catalyst Pharmaceuticals Earnings Date?
Catalyst Pharmaceuticals will release its next earnings report on 06 Nov 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.